Investor Moves
| Name | Value | Action | Change | Price | Last Price |
|---|---|---|---|---|---|
Ken GriffinCitadel Advisors $-13.7K ExitQ1 2026 $14k -- $0.7054 | |||||
News
prnewswire.comWallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offeringprnewswire.comJun 18
businesswire.combioAffinity Technologies Announces Closing of $3.2 Million Offeringbusinesswire.comJun 18
prnewswire.comWallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offeringprnewswire.comJun 17
businesswire.combioAffinity Technologies Announces Pricing of $3.2 Million Offeringbusinesswire.comJun 17
seekingalpha.combioAffinity Technologies, Inc. (BIAF) Discusses Noninvasive Testing and Risk Stratification for Indeterminate Lung Nodules Transcriptseekingalpha.comJun 17